PDE5A and chronic obstructive pulmonary disease: Since Sildenafil improves exercise capacity and quality of life in PAH patients [58] and pulmonary hemodynamics at rest and during exercise in patients with COPD-associated PH, it seems that inhibition of PDE5 could be a reliable target for patients suffering from vascular alterations.